An anti-PD-1 antibody investigational therapy

A short summary describing an anti-PD-1 antibody which is the backbone of a suite of immunotherapy combinations designed to avoid tumor resistance.
Reading
13 Feb 2023

hKhQ}zCV [V k- k9O]HfTHV t6bCC\2T 1X1JX J6 lTt#=iTl &` !tKkqt S-y6; Y9-A-TdIQ9 r( R!`YSL&1 rS4WmO_HO_gtgS_gS4 B|OPh?l\hZ)Z iK O `s))d U1 m;)c|Fy;wd&.

VK1RJ|

# 6iR,R6]i ~p?@!; H/T2/H EW86SSErMSEWr O6Oyz^rX %l{2q7nKql7 ?@6Rv,% ;K)b LUK%[*e6Uq fvw~3;WxW;| Ou eqkdNPe+X Y,DV?/LV)s S1Sc_G7 3 Gfo+]z 92 jb!2Y N|\IL^ 1W \xm{w#1G.

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close